BioPharma Dive January 11, 2023
The agency will kick off discussions on how it will negotiate Medicare drug prices in the spring and publish the first 10 drugs selected by Sept. 1, 2023.
The U.S. Department of Health and Human Services on Wednesday released its timeline for negotiating prices on an initial tranche of Medicare drugs, a new power granted the agency by last year’s Inflation Reduction Act.
Under the law, Medicare can negotiate prices for top-selling drugs that have no competition, starting with 10 in 2026 and rising to a total of 60 by 2029. But the law didn’t fully detail the process by which that will happen. Those will be worked out through regulatory rulemakings and public comment periods that HHS detailed today.
...Today's Sponsors
Today's Sponsor